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Available online 30 November 2016Sarcomere assembly is a highly orchestrated and dynamic process which adapts, during perinatal development,
to accommodate growth of the heart. Sarcomeric components, including titin, undergo an isoform transition to
adjust ventricular ﬁlling. Many sarcomeric genes have been implicated in congenital cardiomyopathies, such
that understanding developmental sarcomere transitions will inform the aetiology and treatment. We sought
to determine whether Thymosin β4 (Tβ4), a peptide that regulates the availability of actin monomers for poly-
merization in non-muscle cells, plays a role in sarcomere assembly during cardiacmorphogenesis and inﬂuences
adult cardiac function. In Tβ4 nullmice, immunoﬂuorescence-based sarcomere analyses revealed shortened thin
ﬁlament, sarcomere and titin spring length in cardiomyocytes, associated with precocious up-regulation of the
short titin isoforms during the postnatal splicing transition. By magnetic resonance imaging, this manifested as
diminished stroke volume and limited contractile reserve in adult mice. Extrapolating to an in vitro cardiomyo-
cyte model, the altered postnatal splicing was corrected with addition of synthetic Tβ4, whereby normal sarco-
mere length was restored. Our data suggest that Tβ4 is required for setting correct sarcomere length and for
appropriate splicing of titin, not only in the heart but also in skeletal muscle. Distinguishing between thin ﬁla-
ment extension and titin splicing as the primary defect is challenging, as these events are intimately linked.
The regulation of titin splicing is a previously unrecognised role of Tβ4 and gives preliminary insight into amech-
anism by which titin isoforms may be manipulated to correct cardiac dysfunction.logy, Anat
UK.
).
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The contractile properties of cardiac muscle inﬂuence the ﬁlling be-
haviour of the heart, determining the maximal diastolic volume, there-
by providing a set point for systolic performance via the Frank-Starling
mechanism [1]. Contractile function is ultimately dictated by the prop-
erties of themuscle's constituent sarcomeres, repeated units of uniform
thin and thick ﬁlaments, the relaxed length of which is thought, in ver-
tebrates, to be governed by the giant molecular spring titin [2,3]. Sarco-
mere assembly is a highly orchestrated process, involving multipleomy and Genetics,
co, California 94,080,
ng's College London,
an open access article undprotein components, which dynamically adapts throughout perinatal
heart development to accommodate physiological hypertrophic cardiac
growth. During this period, various myocardial proteins, including my-
osin heavy chain (MyHC) [4], troponins [5], tropomyosin [6] and titin
[7], undergo an isoform switch from foetal to adult type in order to ad-
just ventricular ﬁlling. Given the association of these genes with human
cardiomyopathies [8–12], novel genetic animal models are required to
provide an understanding of the developmental sarcomere transitions
that are underpinned by splicing [13].
Sarcomere assembly initiates with actin polymerization, prior to
myosin incorporation [14]. Titin acts as a template to ensure the regular
interdigitation and centring of thick and thin ﬁlaments; it undergoes
signiﬁcant isoform transition within the ﬁrst few weeks of postnatal
life, from the longer,more compliant foetal/N2BA isoforms to a predom-
inance of the shorter, stiffer N2B isoform [15]. This coincides with the
period of thin ﬁlament elongation to set adult sarcomere length accord-
ing to the extensibility of the predominant titin isoform [2,15].er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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lular concentration ofmonomeric actin, which ismaintained in complex
with actin-sequestering proteins [16]. Thymosin β4 (Tβ4) is a 43 amino
acid G-actin–binding protein which functions to regulate the cellular
availability of actin monomers for the formation of polymeric F-actin
[17]; along with proﬁlin, it has been shown to mediate the formation
of cytoskeletal actin ﬁlaments in non-muscle cells [18]. The role of Tβ4
in striated muscle sarcomere assembly has not been examined to date,
although a previous study presumed Tβ4 to be dispensable for cardiac
development and function [19]. In contrast, after close examination of
muscle ultrastructure and detailed cardiac phenotyping, we ﬁnd that
Tβ4 is required for the appropriate regulation of sarcomere length. In
Tβ4 knockout mice, shortened thin ﬁlament length, associated with
precocious up-regulation of the shorter isoforms of titin during the
postnatal splicing transition, contribute to reduced stroke volume and
reduced contractile reserve in adults. A direct role for Tβ4 was
conﬁrmed by extrapolation to in vitro culture of embryonic
cardiomyocytes, whereby the titin splice defect was corrected with
addition of synthetic Tβ4 to restore normal sarcomere length. The
developmentally regulated titin isoform transition is frequently recapit-
ulated, or reversed, in disease [20]; examples include elevated
N2B:N2BA underlying abnormal relaxation in diastolic heart failure
[21] and an up-regulation of the more compliant N2BA isoform to cor-
rect for myocardial stiffening in patients with end-stage systolic failure
[22] and severe coronary artery disease [23]). The RNA binding protein
RBM20, linked to human dilated cardiomyopathy [24], was found to
mediate splicing of some titin exons [25]; mutations in RBM20 resulted
in persistence of the large embryonic isoform N2BA-G into adulthood.
However, whether RBM20, or other splicing factors, specify inclusion
of titin's N2B and N2A exons during the postnatal transition, and in
disease, remains to be determined. Understanding the mechanisms
that control titin splicing and identifying splicing regulatorsmay inform
approaches for therapeutic targeting and correction of cardiac
dysfunction.
2. Materials and methods
Detailed methods are provided in the online Supplement. All proce-
dures involving the use and care of animals were performed in accor-
dance with the legislation of the Home Ofﬁce (UK) and approved by
UCL and University of Oxford Animal Welfare and Ethical Review
Boards.
2.1. Global Tβ4 KO mice
Global Tβ4 KO mice were generated as previously described [26].
2.2. MR image acquisition
Mice were anaesthetised with isoﬂurane and maintained at 37 ±
1 °C during image acquisition. For Dobutamine (40 μg kg−1 min−1)
and Esmolol (5mg kg−1 min−1) stress tests an intraperitoneal (i.p.) in-
fusion line was prepared and connected to an infusion pump (PHP2000
Harvard Instruments, UK). Image acquisition was performed with a
39mmdiameter volume coil (Rapid Biomedical GmbH, Germany). Car-
dio-respiratory monitoring and gating were performed using an MR-
compatible system (SA Instruments, NY). Imaging was performed
using a 9.4 T VNMRS horizontal bore scanner (Agilent Technologies,
CA) with a shielded gradient system (1000 mT/m). For detailed image
acquisition and analysis protocols, please refer to [27] and the online
Supplement.
2.3. Echocardiographic and haemodynamic assessment of function
Echocardiograms were obtained in 17–18 week old male +/Y and
−/Y mice under isoﬂurane anaesthesia. Using a Visualsonics Vevo2100 using a 22–55 MHz transducer, pulse wave Doppler measure-
ments were obtained across the mitral valve via the apical 4-chamber
view and tissue Doppler imaging for radial velocities via a parasternal
short-axis view. Haemodynamic measurements were performed on
the same mice 3–4 days later under identical anaesthetic conditions.
The LV was cannulated via the right carotid artery using a 1.4-F Millar
Mikro-Tip cannula (SPR-839, Millar Instruments, Houston, Texas). The
right jugular vein was cannulated with stretched polyethylene tubing
for infusion of dobutamine hydrochloride (16 μg kg−1 min−1) to test
contractile reserve. Measurements were obtained after 15min of equil-
ibration via a Powerlab 4SP data acquisition system (ADInstruments,
UK). All data acquisition and analysis was performed blind to genotype.2.4. Force-Ca2+ sensitivity measurement
Solution compositions for force-Ca2+ sensitivity measurements
were determined using an iterative computer programme that uses
published afﬁnity constants [28] to calculate the equilibrium concentra-
tion of ligands and ions. Solutions contain (inmM1): 80MOPS, 15 EGTA,
1 Mg2+, 5 MgATP, 135 (Na+ + K+), 15 creatine phosphate and
20 units ml−1 creatine phosphokinase, pH 7.0 (at 15 °C). Ca2+ concen-
tration was varied using CaCl2. Total ionic strength was 170 mM. Mice
were killed via cervical dislocation. Hearts were rapidly excised and dis-
sected in oxygenated physiological salt solution. Left ventricular trabec-
ulae (width: 80–250 μm, length: 1.0–3.0 mm) were cut and washed
overnight at 4 °C in relaxing solution containing 1% Triton X-100. After
skinning, ﬁbres were stored in 50% glycerol relaxing solution at
−20 °C for experiments within 1 week. Skinned trabeculae were
assessed using an Aurora Scientiﬁc Permeabilized Fibre Test System.
Sarcomere length was set at 2.0 μm in relaxing solution using laser dif-
fraction and experiments were conducted at 15 °C. Isometric force was
measured by transiently shortening the ﬁbre to slack length. Passive
force, measured in relaxing solution, was subtracted from total force
at each Ca2+ concentration to determine active force.2.5. Adult cardiomyocyte isolation, functional assessment and sarcomere
length determination
Murine left ventricular myocytes were enzymatically isolated by
retrograde perfusion of the heart followed by mechanical agitation.
Functional assessment was conducted, within 6 h of isolation, using an
IonOptix-μStep Myocyte Contractility System. Fractional shortening
was assessed via Fast Fourier Transform-based sarcomere length
tracking. [Ca2+] transients were measured in cells loaded with 1 mM
Fura-2-AM (Life Technologies) and 2 μM Pluronic. Imaging of ﬁxed
cardiomyocytes was performed using a Leica TCS SP5 II system. Leica
Application Suite (LAS) AF Lite was used to measure image intensity
over a line segment drawn perpendicular to visible striations. Matlab
was used to locate peaks in the intensity plot and calculate the associat-
ed difference between peaks. The mean difference between peaks for
each cell was considered its sarcomere length.2.6. Embryonic cardiomyocyte culture
Primary cultures of cardiomyocytes were prepared fromWT or Tβ4
KO E18.5 mouse hearts, essentially as previously described for neonatal
cardiomyocytes [29], and cultured at an initial density of 1 × 106 cells
per well in a 6-well plate (with gelatin-coated coverslips for immuno-
ﬂuorescence analysis). After overnight culture in plating medium, cells
werewashed twice in PBS andmedium replacedwithmaintenanceme-
dium containing either PBS (vehicle control) or Tβ4 (100 ng/ml, a kind
gift from RegeneRx Pharmaceuticals). Medium, supplemented with
fresh Tβ4 or PBS, was changed daily and cells were harvested after 1,
5 and 9 days for real time qPCR and immunoﬂuorescence analysis.
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Immunoﬂuorescence was performed on cryosections of diastole-
ﬁxed hearts or on soleus or tibialis anterior muscle and on embryonic
cardiomyocytes using standard protocols and the following antibodies:
sarcomeric α-actinin (SαA; Sigma), Thymosin β4 (Immundiagnostik),
myomesin and cardiac myosin binding protein C (cMyBPC a kind
gift of Elisabeth Ehler/Mathias Gautel), cTnT and cTNI, (Abcam);
N2B, PEVK, N2A, Tmod1 and Nebulin (kind gifts of Siegfried Labeit).Fig. 1. Tβ4−/Y hearts display nohypertrophy orﬁbrosis although cardiomyocytes are slightly sm
reveal no evidence of hypertrophy; consistent with no signiﬁcant re-expression of hypertrop
analysis of Tβ4−/Y myocardium in transverse section revealed a signiﬁcant reduction of myo
J), with more cells at a reduced size compared with +/Y controls (quantiﬁcation in L–N). Ma
R). Scale bars: 1 mm in A applies also to B; 100 μm in C applies to D; 50 μm in H applies to I
except E–G: n = 9 +/Y; n = 13−/Y.Images were acquired using an Olympus IX81 confocal microscope, a
Zeiss AxioImager with ApoTome or a Leica DM6000 ﬂuorescencemi-
croscope with Structured Illumination. Adult heart sections were
stained with hematoxylin and eosin, using a standard protocol, or
Alexa 594-conjugated wheatgerm agglutinin (Invitrogen), accord-
ing to the manufacturer's instructions. Nuclear counts, cell area
and cell counts were performed on sections which had been
anonymised and blinded to genotype, using ImageJ software particle
analysis.aller. Histological sections of Tβ4+/Y (A andC) and−/Y (B andD) littermate adult hearts
hy-related foetal genes, β-MHC (Myh7), ANF (Nppa) or BNP (Nppb) (E–G). Quantitative
cyte cross-sectional (I, compared with +/Y, H) and longitudinal area (K, compared with
sson's Trichrome staining revealed no evidence of interstitial or perivascular ﬁbrosis (O–
, J, K; 200 μm in O applies to P and 25 μm in Q applies to R; n = 6 hearts per genotype,
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ventricle
Hearts were ﬁxed in diastole by injection of 100mMKCl into the left
atriumofmice, while anaesthetisedwith isoﬂurane. After rapid arrest in
diastole, 4% PFA in phosphate buffered saline (PBS) was perfused for 2–
3 min before hearts were removed and incubated in the same ﬁxative
for a further 2 h. After washing with PBS and embedding in Tissue-Tek
O.C.T. compound, hearts were rapidly chilled in isopentane, within a
dry ice bath. 7 μm thick sections were prepared and stained, as de-
scribed above. Confocal images were obtained using an Olympus IX81
confocal microscope (6 left ventricular ﬁelds of view per section from
3 sections at different levels through the heart, from 5−/Y and 3 +/Y
hearts). Images were analysed in ImageJ (http://rsb.info.nih.gov/ij),
with 1D plot proﬁles drawn along the myoﬁbril, perpendicular to the
Z-lines. Well-deﬁned peaks were obtained, as shown in Fig. 2T, in
which major peaks represented α-actinin positive Z-lines and minor
peaks represented Tmod-1 positive thin ﬁlament ends. Sarcomere
length (SL) was measured as the distance between 2 α-actinin peaks
(at their centres, via a perpendicular line) and TFL as the distance be-
tween an α-actinin peak and a Tmod1 peak.
2.9. Analysis of titin isoforms by SDS-PAGE
Hearts were homogenized in sample buffer containing 8Murea, 2M
thiourea, 3% SDS, 75 mM DTT, 10% glycerol, bromophenol blue and
0.05 M Tris·HCl, pH 6.8 (samples prepared as described in [23]). Sam-
ples were incubated for 5 min on ice and boiled for 5 min at 95 °C,
followed by centrifugation. Agarose-strengthened SDS-PAGE (2% poly-
acrylamide; 0.5% agarose) was performed, at 2 mA overnight, and
protein bandswere visualized, following Coomassie brilliant blue stain-
ing, and scanned using a ChemiDoc system (BioRad). Densitometry
analysis was performed using ImageJ to determine relative intensities
and % total titin.
2.10. RNA isolation and qRT-PCR
Total RNA was isolated from the ventricles using Trizol reagent
(Invitrogen) or from embryonic murine cardiomyocytes using the
RNeasy Plus Micro kit (Qiagen), and reverse-transcribed using Super-
script III RT (Invitrogen). Real-time RT-PCR analysis was performed on
anABI 7900 SequenceDetector using SYBRGreen (Applied Biosystems).
Datawere normalised againstHprt1 expression and fold-changes deter-
mined by the 2−ΔΔCTmethod [30]. Primer sequences can be found in the
online Supplement.
2.11. Statistical analysis
For the comparison of LV baseline data, a two-tailed unpaired
Student's t-test was used to determine any signiﬁcant differences
( p b 0.05). The requirements for a t-test were assessed using a
Shapiro-Wilk test for normality and an F-Test to compare the vari-
ances. For the comparison of functional indices at rest and under
Esmolol treatment, a two-way ANOVA with Bonferroni correction
was used. Dobutamine MRI, ECHO and haemodynamic data were
analysed using a two-tailed Mann–Whitney test with multiple cor-
rection. TFL vs SL correlation was analysed by linear regression. Sta-
tistical analysis was performed using R software version 2.8.1,
GraphPad Prism 5.01 or SPSS 22.
3. Results
3.1. Sarcomere length is dysregulated in Thymosin β4 KO mice
Global loss of Tmsb4x in a mousemodel causes a partially penetrant
hemorrhagic vascular phenotype and loss of 20% of hemizygous nullmales (−/Y) prior to birth, due to mural cell insufﬁciency [26]. We
sought to examine the consequences of Tβ4 loss on myocardial histolo-
gy and function in surviving−/Y adult mice. At the level of gross anat-
omy and hematoxylin/eosin staining of diastole-ﬁxed transverse
sections, hearts displayed no overt abnormality (Fig. 1). Histologically
there was no explicit indication of hypertrophy (Fig. 1, A–D), although
chamber volumes appearedmarginally smaller in−/Ymice. According-
ly, no differences were recorded in MRI-measured left ventricular mass
(Table A1), nor was there any signiﬁcant re-expression of hypertrophy-
related foetal genes,β-MyHC (Myh7), ANF (Nppa) or BNP (Nppb) (Fig. 1,
E–G). A modest, yet signiﬁcant, reduction of myocyte cross-sectional
area was detected in Tβ4−/Y hearts in transverse section, with more
cells at a reduced size per imaged ﬁeld, compared with +/Y controls
(Fig. 1, H\\N). Masson's Trichrome staining revealed no evidence of
interstitial or perivascular ﬁbrosis (n = 6 hearts per genotype;
Fig. 1, O–R).
Due to the role of Tβ4 in regulating the availability of G-actin, re-
quired for thin ﬁlament formation, we focused our analyses on the car-
diac sarcomere. Assessment of the major components was performed
using immunoﬂuorescence on transverse diastole-ﬁxed adult heart
sections. Phalloidin stains thin ﬁlaments of the I band which extend as
bands of reduced brightness either side of the Z line (bright banding,
white arrowheads, Fig. 2A; schematic Fig. 2I). H bands, which contain
only thick ﬁlaments, appear as distinct dark bands between
phalloidin-stained I bands and were clearly discerned in most +/Y
cardiomyocytes. In contrast, sarcomeres in−/Y hearts appeared either
marginally shorter, in which dark H bands were not detectable, or con-
siderably shorter, which manifested as additional phalloidin bright
bands in between Z lines, due to thin ﬁlament overlap (red arrowheads,
Fig. 2B; schematic Fig. 2I). Shorter sarcomere length was also evident in
−/Y cardiomyocytes upon visualisation of other sarcomeric proteins,
including thick ﬁlament components, such as cardiac myosin binding
protein C (cMyBP-C, Fig. 2C, D), as well as the Z-disc protein α-actinin
(Fig. 2C, D), constituents of the troponin complex (cTNT, Fig. 2E, F)
and the M band protein myomesin (Fig. 2G, H). Further evidence of
shorter sarcomeres was obtained from double staining for components
of the thin and thick ﬁlaments. When stained with α-actinin and
cMyBPC, +/Y myoﬁbrils demonstrated regular, discrete alternating Z
lines and A bands (Fig. 2C). Similarly organised were the alternating M
line - thin ﬁlamentmarkers, myomesin and phalloidin (Fig. 2G). In con-
trast,−/Ymyoﬁbrils displayed abnormally close apposition of Z lines-A
bands (α-actinin/cMyBPC, Fig. 2D) and M line – thin ﬁlaments
(myomesin/phalloidin, Fig. 2H), in N60% of cardiomyocytes examined
(quantiﬁcation based on image analysis of n = 6 hearts per genotype;
8 left ventricular ﬁelds of view per section from 3 sections at different
levels through the heart). The shorter sarcomere length in−/Y myoﬁ-
brils was statistically signiﬁcant when quantiﬁed (1.81 ± 0.09 in +/Y
myoﬁbrils vs 1.52 ± 0.21 in−/Y; p b 0.001, based on phalloidin stain-
ing; Z disc to Z disc measurements on 10 cardiomyocytes per ﬁeld,
from 8 left ventricular ﬁelds of view per section; 3 sections at different
levels through each heart; n= 6 hearts per genotype). Greater variance
in sarcomere length was observed in −/Y cardiomyocytes; notably,
myocytes with shorter sarcomeres were not uniformly distributed
throughout the left ventricle, rather the 62.4% of affectedmyocytes clus-
tered in patches.
In myocardial sections, the angle of tissue relative to the imaging
plane may confound accurate measurement of sarcomere length. We
therefore isolated and imaged ﬁxed cardiomyocytes stained with an
anti-myomesin antibody (Fig. 2J and K) and quantiﬁed sarcomere
length as the distance between peaks across a line perpendicular to stri-
ations (Fig. 2J–L). The mean sarcomere length was signiﬁcantly shorter
in−/Y cardiomyocytes (1.75 μm+/Y, n = 55; 1.68 μm−/Y, n = 63;
p b 0.01) and a striking degree of variability in−/Y sarcomere length
was observed (inter-quartile range 1.64–1.79 μm in−/Y versus 1.73–
1.78 μm in +/Y; Fig. 2M), conﬁrming our measurements in sectioned
hearts, with some as short as 1.18 μm.
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ulating actin ﬁlament formation, we sought to directly determine
whether thin ﬁlament length (TFL) was altered in Tβ4 −/Y hearts,
using immunoﬂuorescence based assayswith quantitative image analy-
sis. Firstly, we stained thin ﬁlaments using an antibody against an ex-
treme N-terminal epitope of nebulin, a large protein that spans the
length of the thin ﬁlament and which was originally proposed to act
as a “thin ﬁlament ruler” by determining where tropomodulin (Tmod)
caps the slow-growing, pointed end [31]. Along with dysregulated
sarcomere length in−/Y hearts, we found TFL to be correspondingly
affected.Whereas uniform nebulin bandingwas observed in+/Y hearts
(Fig. 2N), variation was observed in −/Y hearts, with ~10% of
cardiomyocytes demonstrating thicker banding (Fig. 2O) and ~25%
demonstrating thinner banding (Fig. 2P). Although suggestive of a
shortened thin ﬁlament phenotype, recent studies have questioned
the validity of nebulin as a marker for thin ﬁlament ends [32–35]. For
accurate thin ﬁlament measurements and quantiﬁcation, we directly
determined TFL based on the distance between the pointed end
(Tmod1) and the Z disc (α-actinin; Fig. 2Q–U), as used previously [36,
37]. Quantiﬁcation of distance between peaks in intensity plots
(Fig. 2T) was performed using Image J (n = 3 +/Y; n = 5−/Y hearts
per genotype; 6 left ventricularﬁelds of viewper section from3 sections
at different levels through the heart). By this method, +/Y TFL mea-
sured 1.06 ± 0.05 μm (Fig. 2Q, T, U) whereas −/Y TFL was 0.98 ±
0.09 μm, revealing a more variable, and generally shorter, TFL (Fig.
2R–U). Examples of moderately short and extremely short TFL are
shown in Fig. 2R and Fig. 2S, respectively. By measuring sarcomere
length (SL), as the distance between α-actinin-labelled Z lines, on the
same myoﬁbrils, we found that TFL correlates with SL in both +/Y and
−/Y hearts (Fig. 2V). Equations were TFL = 0.35 SL ± 0.21 and TFL =
0.27 SL ± 0.38, for +/Y and−/Y, respectively. Greater range and vari-
ance in both TFL and SL were seen in−/Y hearts, compared with +/Y
hearts. However, by linear regression analysis, therewere no signiﬁcant
differences between genotypes, in terms of slope, elevation or intercept,
and both slopeswere signiﬁcantly different from zero (+/Y: 0.0006 and
−/Y: b0.0001).
Although it continues to be debated [38–43], a number of studies
support the notion that titin is the primary determinant of relaxed sar-
comere length [2,44], present during the earliest stages of myoﬁbril as-
sembly [14]. We therefore sought to determine the relative expression
of titin isoforms in Tβ4−/Y and control hearts. Two main titin isoform
classes are expressed inmammalianmyocardium [45]. Splicing of exons
49/50 to exon 219 produces the relatively short and stiff N2B isoforms
while additional inclusion of exons 102 to 111 (coding for the N2A ele-
ment), produces the larger andmore compliant N2BA class, with its lon-
ger PEVK segment and additional extensible Ig domains (Fig. 3A and B).
N2B and N2BA isoforms are co-expressed in the cardiac sarcomere;
their relative expression determines myoﬁbrillar extensibility and con-
tractility of themyocardial walls. We investigated isoform expression at
the protein level using antibodies against the N2A and N2B elements
[46]. Since the N2B element exists in both classes of isoforms, N2B-pos-
itive sarcomeres were readily detected in all cardiomyocytes (Fig. 3C
and D), in keeping with the reported expression in rodent hearts [47].
In contrast, N2BA titin (detected with anti-N2A) was only weaklyFig. 2.Dysregulated sarcomere length in Tβ4−/Ymyocardium. Assessment of sarcomeric comp
α-actinin/cMyBPC (C, D), cardiac troponin T (cTNT; E, F), myomesin/phalloidin (G, H). Staining
shortened sarcomeres (B), compared with +/Y (A). Schematic in I illustrates how short sarcom
comparedwith normal diastolic sarcomeres in+/Y hearts (white arrowheads in A), inwhich cl
upon visualisation of Z-disc, thick ﬁlament proteins (α-actinin, D, compared with C; cMyBPC
complex (cTNT, F, compared with E) and M band (H, compared with G). Representative imag
was assessed by ﬁnding peaks within a plot of image intensity (L) over a line perpendicular to
was determined for each cell and the population of means illustrated via box-and-whisker
(p b 0.01). Thin ﬁlament length (TFL) was assessed by examining nebulin/Tmod1 banding (N
actinin (Q–T). In keeping with shortened sarcomere length in−/Y hearts, TFL was found to
1.06 ± 0.05 μm in +/Y hearts; p b 0.001 by 1-way ANOVA). TFL correlates with SL in both
different from zero (+/Y: 0.0006 and −/Y: b0.0001) but were not signiﬁcantly different b
(applies to N–S: 5 μm).expressed and at detectable levels in only 19.8% and 12.9% of +/Y and
−/Y cardiomyocytes, respectively (p b 0.05, n = 5, Fig. 3E–G). In an at-
tempt to quantify the ratio of N2B:N2BA isoform expression, protein
from +/Y and−/Y hearts were resolved on an agarose-strengthened
polyacrylamide gel and stained with Coomassie brilliant blue (Fig.
3H). Gels were digitized and densitometry analyses were performed
using ImageJ (Fig. 3H, I). Although variable, % N2B of total titin was typ-
ically higher in−/Y hearts, in the range of 89.7%–96.1%, compared with
87.8%–93.7% in +/Y hearts. The means 90.5 ± 2.5% (+/Y) vs 92.9 ±
2.6% were not statistically different, likely because of variability and
low sensitivity of this technique (as N2B titin represents 90–95% total
titin in adult rodent hearts, there is little scope to detect weak N2BA
bands (~5%) without saturating the stronger N2B band). To overcome
these difﬁculties, we devised a qRT-PCRmethod to quantify the expres-
sion levels of the alternatively spliced N2A and N2B elements from total
myocardial RNA (based on a similar qRT-PCR assay for rat N2B/N2BA
isoforms [48]). In keeping with shorter sarcomere length, and consis-
tent with the isoform-speciﬁc antibody staining, Tβ4 −/Y hearts
expressed a signiﬁcantly higher proportion of the short N2B isoform
mRNA (Fig. 3J; 93.7 ± 1.3% N2B vs 82.4 ± 3.1% N2B in +Y; p b 0.001;
n = 8). More direct evidence of shortened titin in −/Y hearts was
sought using antibodies against exons 49 (N2B) and 224–226 (PEVK
segment) to assess the length of the variable Ig domain-containing re-
gion. As shown in Fig. 3 K–M, discrete Ex224(green)-Ex49(red)-
Ex49(red)-Ex224 (green) banding can be observed around each Z line
(white arrowheads) in +/Y hearts, whereas the banding cannot be re-
solved to the same extent in−/Y hearts (Fig. 3N–P, conﬁrming a shorter
spring region in −/Y titin, characteristic of the shorter N2B isoform.
Cardiomyocytes that express high levels of N2B titin, relative to N2BA
titin, have a higher passive stiffness, which limits their maximal slack
length [45].
Dysregulated (generally shorter) thin ﬁlament and titin lengthwere
the principal measurable defects in −/Y hearts. Analysis of the Ca2+
regulation of force production using demembranated trabeculae isolat-
ed from wild type and knockout mice showed very similar Ca2+-sensi-
tivity (pCa50 5.94±0.01 and 5.92±0.01 for+/Y and−/Y, respectively)
and therefore the sarcomere length differences are very unlikely to be
due to Ca2+-sensitivity discrepancies. In isolated cardiomyocytes, we
detected no noticeable differences in fractional shortening, nor in
Ca2+ transient magnitudes (Fig. A1).
3.2. Loss of Thymosin β4 impacts cardiac function
Given the variable sarcomere length in Tβ4-null hearts, we sought to
investigate the effect of Tβ4 loss on cardiac function. High temporal res-
olution cine-MRI was performed to assess global functional and mor-
phological parameters in four month old +/Y and −/Y mice (Fig. 4;
Table A1). Both left ventricular (LV) end-diastolic (EDV) and end-systol-
ic volumes (ESV) were signiﬁcantly smaller in−/Y mice (EDV: 57.4 ±
2.2 vs 67.7 ± 1.8 μl in +/Y mice; ESV: 16.9 ± 1.5 vs 23.2 ± 1.4;
p b 0.001, n = 14–16), as apparent from 2-chamber long axis (Fig. 4A,
B (+/Y) vs E, F (−/Y)) and mid-ventricular short axis images (Fig. 4C,
D (+/Y) vs G, H (−/Y)). The combined effect was a lower stroke volume
in−/Y mice (SV; Video 1 online and Table A1), but with an elevatedonents in diastole-ﬁxed adult heart sections (n=5per genotype):ﬁlamentous actin (A, B),
of polymerized actinwith phalloidin revealed that N60% of−/Y cardiomyocytes contained
eres in−/Y hearts present with additional phalloidin bright bands (red arrowheads in B)
ear dark bands are seen either side of the Z line. Shorter sarcomere lengthwas also evident
, D, compared with C; myomesin, H, compared with G), and components of the troponin
es of cardiomyocytes from+/Y (J, n = 55) and−/Y (K, n = 63) mice. Sarcomere length
striations (J, K) and revealed a negative skew in its distribution. Mean sarcomere length
(M). Means (1.75 μm +/Y, 1.68 μm−/Y) were signiﬁcantly different by 1-way ANOVA
\\P) and measured as distance between the peaks, in intensity proﬁle, of Tmod1 and α-
be more variable and, overall, signiﬁcantly shorter in−/Y hearts (U; 0.98 ± 0.09 μm vs.
+/Y and −/Y hearts (V). By linear regression analysis, both slopes were signiﬁcantly
etween genotypes, in terms of slope, elevation or intercept. Scale bars: A–H: 10 μm; N
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wards higher dP/dtmax upon LV haemodynamic assessment suggests
higher baseline contractility in −/Y mice (Table A2). Increased heartrate was consistently observed in Tβ4−Y mice across multiple inde-
pendent experiments (Table A1, A2, A4 and A5) and, while this did
not reach statistical signiﬁcance in any single experiment, the effect,
Fig. 3. Shortened sarcomere length in Tβ4−/Y cardiomyocytes is associated with altered expression of titin isoforms. Titin isoforms containing the N2B element (A, B) were strongly
expressed in all cardiomyocytes of both +/Y and−/Y hearts (n = 5 each; C, D, co-expressed with α-actinin, C′, C″, D′, D″,G). In contrast, the N2A element (B), present only in N2BA
titin, was expressed at detectable levels in only 19.8% of +/Y (E, G) and 12.9% of−/Y cardiomyocytes (F, G; p b 0.5). Separation of N2B and N2BA isoforms on agarose-strengthened
SDS-2% polyacrylamide gels reveals a modestly increased %N2B, with considerable variability. Mean %N2B was not statistically different: 90.5 ± 2.5% (+/Y) vs 92.9 ± 2.6% (−/Y), (H,
I; n = 4). Tβ4−/Y ventricles express a higher ratio of N2B:N2BA titin (J, p b 0.001; n = 8), determined by qRT-PCR. Dual immunoﬂuorescence of titin exons 49 (N2B; red) and 224–
226 (PEVK segment; green) conﬁrms a reduced length of the variable Ig domain-containing spring region in−/Y hearts (N\\P), compared with +/Y hearts (K–M). White arrowheads
indicate position of Z lines. 20 μm scale bar in F″ applies to C\\F. 10 μm, 5 μm and 2 μm in K, L, M, respectively apply to N, O and P. Error bars in G, H: SEM.
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Fig. 4. Thymosinβ4 knockout hearts show reduced ventricular volumes and regional variability inwallmotion. Representative two-chamber long axis (2-ch; A, B, E, F) andmid ventricular
short axis (SA; C, D, G, H) images at end diastole (ED) and end systole (ES) for+/Y (A–D) and−/Y (E–H)mice. Images reveal small ED and ES volumes in−/Ymice. Bulls eye plots reveal a
high local variability in fractional wall thickening (fWT) in−/Y LV myocardium (representative example in J, compared with +/Y, I). Segment-wise comparison of variances (% standard
deviation (%SD) for+/Y (K) and−/Y (L) LV (Table A3; n=8+/Y; n=9−/Y), revealedgreater variability in fWT in anterior (pb 0.05) and inferior segments of–Y LV (L, comparedwith K)
while septal and lateral segments displayed reduced variability (Table A3).
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normal cardiac output (CO, Table A1).
When segmentation techniques were applied, greater regional vari-
ability in % fractional wall thickening (fWT)was apparent in−/Y hearts.
Whereas sector values for+/Y hearts generally ranged from25% to 75%,
a signiﬁcantly wider range of values (5% to 95%) were observed in−/Y
mice (examples in Fig. 4I and J), with considerable variation bothwithin
and between hearts.When fWT standard deviation (SD) was compared
for all +/Y and−/Y LV (Fig. 4K and L; Table A3; n=8+/Y; n= 9−/Y),
a segment-wise comparison of variances revealed that variability was
greater in−/Y within anterior (p b 0.05) and inferior segments, while
septal and lateral segments displayed less variability. When all fWT SD
of +/Y vs−/Y were compared, using an F-test, a p-value of b0.01 was
obtained. Variation in wall motion contributed to a more pronounced
twisting motion in−/Y hearts upon contraction (Video 1 online).
3.3. Tβ4−/Y mice possess a limited contractile reserve
Cardiac dysfunctionmay only become apparent during physiological
or pathological stress. To simulate the effect of exercise, we assessed
cardiac performance in Tβ4 knockout mice subjected to dobutamine
treatment, with high temporal cine MR imaging (n = 4+/Y; 6−/Y
Fig. 5; Table A4; Video 2 online). The inotropic effects of dobutamine,
mediated primarily by β1-adrenergic receptor activity, increase cardiac
output via elevated heart rate and enhanced myocardial contractility.
+/Y control mice (Fig. 5A–D) demonstrated a 15% increase in heart
rate (+87 bpm; Table A4), decreased ESV and 27% increased EF (Fig.
5A–D). The characteristic leftward shift in the time/volume curve (Fig.
5I) is evidence of a normal contractile reserve in +/Y mice. In contrast,
−/Y mice (Fig. 5E–H) already display small ESV (Fig. 5F), elevated heartrate and ejection fraction at baseline, with left-shifted curves, compared
with +/Y (Fig. 5J). The small ESV in−/Y only modestly decreased with
dobutamine treatment (compare Fig. 5F and H versus Figs. B and D); no
discernible leftward shift was observed (Fig. 5J). EFwas elevated by only
10% (p= 0.029ΔBaseline+/Y vs−/Y; Table A4) and heart rate by only
5% (35 bpm; Table A4). Consistentwith a trend towards reducedΔdP/dt
max by haemodynamic analysis (Table A2), these data suggest that, al-
though maximal contractile function per se is not impaired, Tβ4−/Y
mice are restricted in their capacity to increase contractility when re-
quired;−/Y mice appear to utilise a proportion of “normal” contractile
reserve at baseline, to compensate for their reduced end-diastolic vol-
umes. Tβ4−/Y mice depend upon increasing heart rate and EF to com-
pensate for small EDV and maintain an effectively normal cardiac
output (CO; Table A1). Moreover, their limited contractile reserve sug-
gests they are unable to alter stroke volume. We, therefore, predicted
that−/Y mice would struggle to maintain CO during β-blockade and
sought to test this hypothesis by bolus infusion of Esmolol (β1-selec-
tive). Esmolol treatment slowed heart rate and increased EDV and ESV
in both +/Y and −/Y hearts (n = 9+/Y, 9−/Y; Fig. 6A–C; Table A5;
Video 3 online). The reduction in SV upon Esmolol treatment (Δ base-
line), was signiﬁcantly diminished in −/Y mice (Fig. 6D; Table A5;
p = 0.05, Mann Whitney) and CO became signiﬁcantly reduced in−/
Y mice under Esmolol treatment (Fig. 6E; Table A5; p b 0.05, ANOVA).
Tβ4−/Y mice share some features of the murine R193H cTnI muta-
tion model of restrictive cardiomyopathy (RCM) [49]; namely, short ED
sarcomere length, regionalized increases in fractional wall thickening,
reduced EDV, an inability to increase cardiac output in response to β-
adrenergic stimulation or to reduce stroke volume in response to β-
blockade. We therefore assessed haemodynamic function by pressure-
volume loop analysis (Table A2) and by Doppler echocardiography
Fig. 5. Tβ4−/Ymice possess limited contractile reserve.Mid-ventricular short axis images, at baseline and under dobutamine stress, were acquired at high frame rate. Tβ4+/Y: A–D; Tβ4
−/Y: E–H. End systolic volume at baseline of Tβ4−/Ymice (F) is considerably reduced comparedwith control (+/Y)mice (B; TableA4; n=4+/Y, 6−/Y), limiting the extent towhich LV
contractility can be further increased under dobutamine stress (Tβ4 +/Y: D; Tβ4−/Y: H). Representative volume curves for +/Y (I) and−/Y mice (J) demonstrate reduced contractile
reserve (characteristic leftward shift, as observed in +/Y) in−/Y mice upon β-adrenergic stimulation (shown for n = 2 each genotype).
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the respective techniques, to deﬁnitively conﬁrm a phenotype of dia-
stolic dysfunction or RCM in Tβ4−/Y mice.
3.4. Sarcomere length is also dysregulated in skeletal muscle of Thymosin
β4 KO mice
In order to determine whether the shortened sarcomere phenotype
in Tβ4 KOmice is speciﬁc to the heart, we examined skeletal muscle for
evidence of a similar dysregulation. Soleus and tibialis anterior (TA)
muscles fromTβ4−/Ymice (n=5) and+/Y controls (n=3)were sec-
tioned in a longitudinal plane and stained for multiple sarcomere pro-
teins. Shortened sarcomere length was evident in both soleus and TA
muscles from−/Y mice (data from soleus shown in Fig. A2). Closer ap-
position of Z- and M- bands was revealed with dual myomesin/
phalloidin staining (A +/Y vs B−/Y); shortened titin was conﬁrmed
by the reduced spacing of the N2A element (C +/Y vs D−/Y). We con-
clude that the requirement for Tβ4 for appropriate sarcomere/titin
length is not speciﬁc to the cardiac muscle but common to postnatal
striated muscle types.
3.5. Dysregulation of sarcomere length and titin isoform transition occur in
Tβ4 KO mice during postnatal cardiac growth
Having demonstrated a shorter PEVK spring region and an elevated
ratio of N2B:N2BA titin in−/Y adult hearts, consistent with shortened
sarcomeres and altered function, we sought to track the postnatal titin
isoform transition, together with sarcomere length, over the course ofdevelopment to determine the earliest appearance of the phenotype.
It has been shown that embryonic day 16 (E16) rat hearts exclusively
express a long and compliant N2BA titin but no N2B titin [15]. Around
birth, down-regulation of the N2BA isoform coincides with up-regula-
tion of the less extensible N2B isoform to reach N90% N2B by around
P21, thereby increasing titin-based passive stiffness. In diastole-ﬁxed
sectioned hearts, −/Y sarcomeres, were indistinguishable from +/Y
controls until postnatal day 5 (P5; Fig. 7A; B; n = 3–7 per genotype,
per stage) p b 0.001). By P21 and into adulthood, sarcomeres were
30–40% shorter in −/Y mice (p b 0.001, Fig. 7A–B). +/Y embryos
displayed the expected transition from exclusively N2BA titin to pre-
dominantly N2B titin during late embryonic and early postnatal devel-
opment (Fig. 7C, D). Since N2BA titin contains both N2B and N2A
elements, the qRT-PCR-based assay does not reﬂect the complete ab-
sence of N2B that has been demonstrated in embryonic heart but accu-
rately tracks the N2BA-N2B transition in relative terms. An equivalent
N2BA-N2B switch was observed in−/Y embryos from E14.5 through
to P1 (Fig. 7C), at which point the less compliant N2B became preco-
ciously expressed, to signiﬁcantly elevated levels by P5, and remained
proportionally higher in −/Y hearts throughout later development
(Fig. 7C, D). The titin transition was also monitored by dual immunoﬂu-
orescence with exon 49/exon 224 (N2B/PEVK segment) antibodies. In
+/Y and−/Y hearts, maturing sarcomeres show appropriate organisa-
tion of N2B/PEVK banding, around the Z line, by P1, although, unexpect-
edly, N2B staining was comparatively weaker in both mutant and
controls at stages pre-P5 (Fig. 7E). Whereas the discrete banding
remained visible in +/Y hearts throughout the P1-P5-P21 transition,
the N2B and PEVK bands in−/Y hearts became closely apposed from
Fig. 6. Tβ4−/Y mice are unable to adequately alter stroke volume or maintain cardiac output during β-blockade. Representative mid ventricular short axis slices showing that Esmolol
treatment increased EDV and ESV in both +/Y and−/Y hearts (A–C; Table A5). Esmolol treatment (hatched boxes) reduced stroke volume (SV) in +/Y mice, whereas−/Y mice were
unaffected (D), and cardiac output dropped signiﬁcantly compared with that of +/Y mice (E). *: p b 0.05; **: p b 0.01. n = 9 +/Y, 9−/Y.
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shortened sarcomere phenotype in Tβ4−/Ymice arises early in postna-
tal life, coincidentally with precocious up-regulation of shorter titin iso-
forms; reduced sarcomere length is maintained throughout adulthood
in a large proportion of cardiomyocytes.
3.6. Correct sarcomere length can be restored with exogenous Thymosin β4
The developmental isoform transition can be accurately recapitulat-
ed in cultured cardiomyocytes from late embryonic hearts. Primary car-
diomyocyte culture allows for direct manipulation of titin splicing by
growth factors or mechanical parameters, as demonstrated using thy-
roid hormone in rat cardiomyocytes [48]. In order to conﬁrm that
short sarcomere length and altered titin splicing were a direct conse-
quence of Tβ4 loss and not secondary to another effect, such as coronary
vascular insufﬁciency, we sought to rescue−/Y sarcomere growth viasupplementation of culture medium with synthetic Tβ4. We found
that E18.5 murine cardiomyocytes displayed the same N2BA-N2A tran-
sition reported for rat [48] (Fig. 8). Wild type (WT) cardiomyocytes
displayed an organised sarcomere (Fig. 8A) and synchronous contractil-
ity. Cardiomyocytes from Tβ4 knockout (KO) hearts, while contractile,
were disproportionally elongated and narrower in shape compared
withWT, with excessive branching and sarcomeres whichwere shorter
in length (Fig. 8A) and severely disrupted in places (arrowheads, Fig.
8A). The shorter sarcomere length in KO cardiomyocytes coincided
with a higher proportion of N2B titin from day 5 of culture, reaching
levels that were 22.7% higher than WT by day 9 (Fig. 8B; p b 0.001;
n = 6 from 3 independent experiments). Culturing in the presence of
100 ng/ml Tβ4 resulted in KO cardiomyocytes that were correctly pro-
portioned, comparable in length and width to WT cardiomyocytes
with organised sarcomere structure. Sarcomere length was restored to
control level (Fig. 8A and C, p b 0.001) and this coincided with
Fig. 7. Dysregulation of sarcomere length and titin isoform transition occur in Tβ4 KOmice during postnatal cardiac growth. Tracking sarcomere maturation through late embryonic and
postnatal development (A, phalloidin staining) reveals the earliest evidence of shortened sarcomeres in−/Y hearts at P5 (B; p b 0.001; n = 3–7 per genotype, per stage). +/Y embryos
displayed the expected postnatal transition from predominantly N2BA titin to predominantly N2B titin (C, D). This was emulated in−/Y embryos until P1, at which point the shorter N2B
isoform became precociously up-regulated and continued to be expressed at an elevated ratio in−/Y hearts throughout later development (C). The titin transition visualized by dual
immunoﬂuorescence with exon 49/exon 224 (N2B, red/PEVK segment, green) antibodies (E). Discrete N2B/PEVK banding, around the Z line, is seen in+/Y hearts throughout the P1-
P5-P21 transition, whereas, in−/Y hearts, bands become closely apposed from P5 onwards, such that discrete bands could not be discerned. Scale bar in A (all panels): 20 μm. Scale
bar in E (all panels): 10 μm *: p b 0.05; **: p b 0.01; ***: p b 0.001. Error bars in B, C: SEM.
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p b 0.01 + Tβ4 vs –Tβ4 in KO cardiomyocytes). In cardiomyocytes,
Tβ4 exists throughout the cytoplasm and the nucleus and binds both
G-actin and actin ﬁlaments (Fig. A3A, B), as previously reported [50]. In-
terestingly, upon addition of exogenous Tβ4, either to WT or KO
cardiomyocytes, Tβ4 bound ﬁlamentous actin and, strikingly, accumu-
lated in and around the nucleus (Fig. A3C, D and G, H, respectively).
Tβ4 treatment reportedly alters gene expression [51] but there is no in-
sight into the mechanisms via which this is achieved. While the effects
of Tβ4 to rescue sarcomere growth and maturation may be mediated
via thin ﬁlament extension, a direct role in titin splicing cannot be ex-
cluded. Indeed, a number of splicing factors were found to be differen-
tially expressed in postnatal −/Y hearts; by qRT-PCR, the serine/
arginine-rich splicing factors (SRSFs) 1, 2, 3 and 7 and SFPQ were up-
regulated whereas SRSF5 was down-regulated at P21 (Fig. A4, n = 3),
consistent with altered splicing in the absence of Tβ4. Further studies
are now required to delineate themechanisms bywhich Tβ4 inﬂuences
sarcomere length and/or splicing of genes, including titin.4. Discussion
Sarcomere assembly is a highly orchestrated process, which requires
dynamic adaptation in order to accommodate hypertrophic cardiac
growth during perinatal development; sarcomeric proteins undergo
isoform switching from foetal to adult type during this period to adjust
ventricular ﬁlling [7]. We reveal that mice lacking the actin monomer
binding protein, Tβ4, fail to appropriately regulate sarcomere length,
due to a precocious titin isoform transition postnatally and predomi-
nance of the less compliant isoforms through to adulthood. Dysregulat-
ed sarcomere length manifests as reduced ventricular volumes,
diminished stroke volume and a dependence upon raising heart rate
and force of contraction for maintenance of a near normal cardiac out-
put. Under conditions of altered cardiac demand, Tβ4−/Y mice were
limited in their ability to increase heart rate and ejection fraction in re-
sponse to the β1-adrenergic receptor agonist dobutamine. As predicted,
−/Ymicewere unable to alter stroke volumewhen treatedwith theβ1-
selective antagonist Esmolol, resulting in a further reduction of cardiac
Fig. 8. Appropriate sarcomere length can be restoredwith exogenous Thymosin β4. The N2BA to N2B titin postnatal isoform switch can be recapitulated in cultured cardiomyocytes from
E18.5 mouse hearts. A: Wild type (WT) cardiomyocytes displayed an organised sarcomere whereas those from Tβ4 knockout (KO) hearts were shorter in length and partly disordered.
Supplementation of culture medium with 100 ng/ml synthetic Tβ4 restored normal morphology and sarcomere organisation in KO cardiomyocytes. Rescue coincided with restoration
of normal titin splicing (B; p b 0.01 + Tβ4 vs –Tβ4 in KO cardiomyocytes) and sarcomere length (C), by day 9 in culture. A summary schematic (D) to illustrate the shortened titin and
sarcomere/TFL in Tβ4−/Y cardiomyocytes. The precise mechanism by which Tβ4 impacts titin splicing and/or TFL remains unclear; two possibilities are depicted i) a direct effect on
ﬁlament extension by regulating the availability of G-actin monomers or ii) a direct effect of titin splicing, via incorporation into splicing complexes, which may also include
monomeric nuclear actin. Scale bar in A: 20 μm. *: p b 0.05; ***: p b 0.001, +Tβ4 vs –Tβ4, or as indicated by lines. ††: p b 0.01, KO vs WT. n = 6 per genotype from 3 independent
experiments. Error bars in B, C: SEM.
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compromised in their ability to adapt under (patho-)physiological con-
ditions. A previous study reported that Tβ4 was dispensable for cardiac
development and that cardiac function was unaffected in knockoutmice [19]; although left ventricular internal diastolic dimensions were
shown to be reduced, consistent with the phenotype reported herein,
the sarcomeric defects and compensated cardiac function were not ex-
plored. We found the short sarcomere phenotype to be present also in
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splicing more broadly, rather than as a cardiac-speciﬁc regulator of
splicing. These ﬁndings, alongwith our demonstration of aberrant post-
natal titin splicing transition in vitro, may suggest dysregulated sarco-
mere length as a primary effect, rather than an adaptive response to
compensate for altered cardiac function.
Thin ﬁlament length is controlled cooperatively by a number of mo-
lecular regulators. Titin, as explored in this study, has a primary role but
is, by no means, the only player. Tmod1, the cardiac member of the
Tropomodulin family, binds tropomyosin and actin ﬁlament pointed-
end capping proteins to regulate thin ﬁlament length [52,53]. Tight cap-
ping of the slow-growing pointed ends by Tmod was believed to main-
tain uniform TFL, however, sarcomeres have since been shown to be
dynamic, with TFL shortening [54] and elongation [55] possible, despite
the presence of capping proteins. That said, the importance of Tmod in
protecting the pointed end, at least in skeletal muscle, was conﬁrmed
with the recent demonstration that thin ﬁlament elongation in dystro-
phic muscle depends upon proteolysis of Tmod to expose free pointed
ends [55]. At the fast-growing (barbed) ends, the thinﬁlament is capped
by CapZ to retard actin ﬁlament assembly [56]. CapZ was proposed to
play a role in the dynamic TFL adaptation that occurs in cardiomyocytes
in response to mechanical stimulation, as a surrogate for the effects of
exercise/hypertrophy on cardiac muscle [57]. The giant F-actin binding
protein, Nebulin, spans the length of the thin ﬁlament, its C-terminus
binding the Z-disc and its N-terminus binding near the pointed end
[58]. Nebulin was postulated to act as a thin ﬁlament “ruler” (discussed
in [59] and [60]), however, the notion was subsequently challenged
with the demonstration that nebulin does not extend to the pointed
ends, where Tmod caps thin ﬁlaments [32]. The role of nebulin, rather,
appears to be to stabilize a large core region of the thin ﬁlament and
generate uniform TFLs in skeletal muscle [34], whereas nebulette, a
smaller nebulin homologue in cardiac muscle, stabilizes a comparative-
ly shorter core region to allow individual TFLs to vary according to
working SLs in the heart [34]. Although TFL in Tβ4−/Y hearts correlated
with shorter titin isoform expression, the potential inﬂuence via other
regulators would be worthy of future investigation.
In reconciling the requirement for Tβ4 at the level of sarcomere
growth during development, it is a signiﬁcant challenge to distinguish
whether the primary defect is in thin ﬁlament extension or in regulation
of titin splicing, events which are intimately linked (Fig. 8D). While an
alteration in actin ﬁlament formation may, at ﬁrst, seem more likely,
given the recognized function of Tβ4 in G-actin sequestration, titin has
been regarded as one of the molecular “rulers” that dictates half sarco-
mere length and mature thin ﬁlaments extend according to the size of
the predominant titin isoform; consistentwith this are the observations
that titin is present during the earliest stages of premyoﬁbril assembly
[14].β-Thymosins act as actin bufferingmolecules tomaintain highmo-
nomeric actin concentrations, even though intracellular ionic conditions
favour its complete polymerization to F-actin [61]. Proﬁlin-dependent
dissociation of G-actin-Tβ4 complexes liberates actin for ﬁlament as-
sembly [62]. Thus polymerization is not achieved by regulating the
actin sequestering activity of Tβ4 itself; rather by actin desequestering
agents, under the regulation of upstream signalling [63]. Indeed, in sup-
port of this, a recent study documented that over-expressing proﬁlin led
to sarcomere elongation, myocyte hypertrophy and impaired function
[64]. In Tβ4−/Ymice, thin ﬁlaments are not impaired in their formation
and should, therefore, be able to elongate via the same mechanisms.
Other G-actin binding proteins presumably compensate for the lack of
Tβ4, at least for early sarcomere assembly. Whether a depleted Tβ4-
buffered monomer pool limits sarcomere remodelling during develop-
mental cardiac growth remains unresolved but, on balance, disruption
of actin ﬁlament formation does not appear to underpin themutant sar-
comere phenotype.
An alternative explanation, worthy of future mechanistic explora-
tion, is that splicing of titin is directly regulated by Tβ4. Tβ4 translocates
to the nucleus and may function to sequester nuclear actin, a keycomponent of splicing complexes [65]. In support of this, a putative
role in pre-mRNA splicing has also been proposed for proﬁlin [66],
which functions, like Tβ4, to sequester actinmonomers and our data re-
veal altered expression of splicing factors in Tβ4−/Y mutants, which
may be an attempt to compensate for altered function. In addition, the
cellular localisation and activity of splicing factors of the SRSF family is
regulated by Akt-mediated phosphorylation and the developmental
titin isoform transition has been shown to be principally regulated via
phosphatidylinositol 3-kinase/Akt-dependent signalling [48]. Tβ4
forms a functional complex with PINCH and integrin-linked kinase, to
regulate Akt activation [67] and this intersection with the splicing ma-
chinery may alternatively explain the requirement for Tβ4 for correct
titin splicing.
Processing of titin pre-mRNA is subject to subtle regulatory mecha-
nisms that control entry to either N2B or N2BA splice pathways.
RBM20, a member of the SRSF family, regulates the splicing of many
genes that are linked to cardiomyopathy, including titin [25]. A loss-
of-function mutation in human RBM20, when modelled in rats, results
in a DCM-like phenotype due to persistent expression of a giant foetal
titin isoform (N2BA-G) in adult heart. Whilst RBM20 expression was
not signiﬁcantly altered in Tβ4−/Y postnatal hearts, its function may
be adversely affected. It remains to be determined whether RBM20, or
a related SRSF, could also direct the splicing machinery towards en-
hanced production of the N2B isoform and dysregulated sarcomere
length.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.yjmcc.2016.10.010.
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